Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected3M Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | MRNA | AMGN | GILD |
|---|---|---|---|
| Return | |||
| Last Price | — | 437.39 | 150.53 |
| Daily Change | — | − 1.52% | − 0.46% |
| Period ReturnPast 3 Months | + 217.64% | + 32.73% | + 14.68% |
| Valuation | |||
| Market Cap | $58.1 B | $236 B | $187 B |
| P/E Ratio | — | 27.16 | — |
| Dividend Yield | — | 3.21% | 3.98% |
| Net MarginTrailing 12M | — | 23.0% | 10.6% |
| Risk | |||
| Beta | — | 0.45 | 0.40 |
| 52-Week Range | — | 269.77 — $447.03 | 108.46 — $157.29 |
| Company | |||
| Sector | Health Care | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Biotechnology |
Company
- MRNAHealth Care · Biotechnology
- AMGNHealth Care · Biotechnology
- GILDHealth Care · Biotechnology
Metrics could not be loaded for MRNA: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 22:53
To Understand This